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ABSTRACT
Background: TKIs are a long-term treatment for GIST, and may have an impact on caregivers.
Material and Methods: For this cross-sectional study, patients and caregivers were both included
when patients had been treated with TKIs for at least six months. Caregivers completed questionnaires
including demographics, distress (Hospital Anxiety and Depression scale), burden (Self-Perceived
Pressure from Informal Care) general health (RAND-36), comorbidity (Self-administered Comorbidity
Questionnaire), social support (Social Support List – Discrepancies) and marital satisfaction (Maudsley
Marital Questionnaire). Patients completed similar questionnaires, without ‘burden’. We conducted
analyses to explore differences between caregivers with low/moderate versus high levels of burden
and low versus high levels of distress.
Results: Sixty-one out of seventy-one eligible couples (84%) were included in the analysis. The median
age of the caregivers was 60 years; 66% were female and 78% were the patients’ spouse. The median
age of the patients was 66 years; 43% were female. Caregivers experienced high levels of burden and
distress in 10% and 23%, respectively. Caregivers with high levels of burden perceived significantly
lower mental health, less vitality, lower general health and high levels of distress. Significantly higher
levels of burden were found in non-spouses, caregivers of patients with more treatment-related
side-effects, caregivers who spent more hours caring, and those caring for more than one person. For
distress, caregivers with high levels of distress perceived significantly more burden, lower social func-
tioning, more role physical and emotional problems, lower mental health, less vitality and lower gen-
eral health. Furthermore, high levels of distress were found in caregivers of more dependent patients
and those caring for more than one person.
Conclusions: Caregivers of the patients with GIST treated with TKI are managing well. There is a small,
vulnerable group of caregivers with high levels of burden and/or distress, show more health-related
problems, both physical and mental, and require adequate support.
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Introduction
Gastro-intestinal stromal tumours (GIST) belong to the rare
and heterogeneous group of soft tissue sarcomas. Curative
treatment consists of radical surgery, in high risk tumours
combined with (neo) adjuvant imatinib [1]. Currently, the
duration of adjuvant therapy is three years [2]. Until 2000,
the treatment of GIST was limited, as GIST are resistant to
chemo- and radiotherapy. In 2000, imatinib, a tyrosine kinase
inhibitor (TKI), was introduced as the first targeted treatment
for metastatic GIST. This significantly improved median over-
all survival from <1 year to >5 years nowadays, causing a
change in life perspective for these patients [2]. Imatinib in
GIST has been a successful, often prolonged, targeted treat-
ment for GIST, both in the adjuvant and metastatic setting.
More attention has recently been given to the chronicity of
the disease, including the need for treatment with other TKIs
when resistance to imatinib develops. This had led to the so-
called Sword of Damocles, fear of recurrence or progression
[3]. The approach to GIST patients and their caregivers and
their needs had therefore evolved [4]. Chronic oral treatment
may be accompanied by side-effects, such as, fatigue, diar-
rhea, nausea, periorbital oedema, muscle cramps and skin
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rash [5]. These adverse events, frequent radiological evalua-
tions and related uncertainties may have an impact on
patients’ personal lives. We previously demonstrated that
around one third of GIST patients on TKIs experience high
levels of fear of cancer recurrence or progression. They also
experience high levels of distress, functional impairment
(emotional, social, cognitive) and have difficulties making
plans for the future [3]. In a study of prostate cancer
patients, treated with curative intent, we found that fear of
cancer recurrence did not only adversely affect patients, but
also their caregivers [6]. Little is known about how GIST and
its (chronic) treatment may impact informal caregivers, while
chronic fatigue, nausea and diarrhoea may conceivably
impact the partner or the family. Studies have shown that
cancer not only affects the individual patient and caregiver
separately, but also their intertwined life as a couple [7,8].
Patients’ longer-term mechanisms for coping with cancer
and its treatment are influenced by difficulties experienced
by their caregivers. Caregivers may even perceive levels of
burden, distress, anxiety and decreased social support that
are greater than the patient during the cancer treatment tra-
jectory [8]. Burden is defined by Zarit et al., and mentioned
in the review of Adelman et al., as ‘the extent to which care-
givers perceive that caregiving has had an adverse effect on
their emotional, social, financial, physical and spiritual
functioning’ [9,10]. This definition shows that burden is a
multidimensional experience. Known risk factors for higher
levels of perceived burden are diverse, but most well recog-
nised are demographic factors, such as being female and liv-
ing with the recipient of care, psychosocial factors (especially
depression), fewer coping strategies and social isolation [10].
Furthermore, patient distress, spending more hours caring
for the patient, financial stress, a lack of choice in becoming
a caregiver and discontinuation of their own employment
are risk factors [10]. High levels of burden may negatively
interfere with the caregivers’ general health, both physical
and mental [11,12]. Distress, defined by the National Cancer
Institute as ‘emotional, social, spiritual of physical pain or suf-
fering that may cause a person to feel sad, afraid, depressed,
anxious or lonely’, is an important psychological morbidity,
which often coincides with burden [10,13]. Risk factors for
distress are wide ranging, however worry about treatment-
efficacy, managing side-effects, social isolation, lack of prep-
aration in caring for a significant other and complexity of
care are identified as more specific for caregivers of patients
on active treatment for cancer [13].
With this cross-sectional study, we aim to explore the
well-being of caregivers of patients with chronic TKI treat-
ment, by measuring burden, distress, general health, discrep-
ancies in social support and marital satisfaction. Furthermore,
we will explore whether there are the differences in care-
givers experiencing high levels of burden and distress versus
caregivers with low/moderate levels of burden and low levels
of distress. To the best of our knowledge, this is the first
study exploring well-being of caregivers of patients with
GIST treated with TKIs, and is also one of the few studies




The cross-sectional study was conducted between June 2013
and May 2014 in the Departments of Medical Oncology at
three hospitals in different regions of the Netherlands; two
university medical centres and one regional hospital.
Inclusion criteria for patients were: age older than 18 years,
able to communicate in Dutch language, TKI treatment for at
least six months in either the adjuvant or palliative setting,
having an informal caregiver. Exclusion criteria for the
patients were: prognosis of less than 12 weeks, able to com-
municate in Dutch language, no informal caregiver. A care-
giver was defined as a person who cared for a patient
during their chronic treatment with a TKI for GIST. This
included a spouse, sibling, friend or other relative. Inclusion
criteria for caregivers were: age older than 18 years.
Exclusion criteria for caregivers were: not able to communi-
cate in Dutch language. When either the patient or the care-
giver met the one of the exclusion criteria, both
were excluded.
Procedure
The study was approved by the local medical ethical com-
mittee (Radboud University Medical Centre 2013/278). All
patients in the database of the Departments of Medical
Oncology of the attending hospitals were systematically
assessed for their eligibility by their attending physician. The
attending physician approached the patient and their care-
giver during an outpatient follow-up visit or by telephone.
When the patient and the informal caregiver gave their ver-
bal informed consent, they were included. They were both
asked to a single complete self-report questionnaires, inde-
pendently of each other. Completing the paper and pencil




Demographic characteristics were obtained with a question-
naire, including gender, age, nationality, education, employ-
ment and relationship with each other (spouse, sibling,
offspring, friend). We inquired whether the patient experi-
enced side-effects of TKI treatment (answer possibilities: ‘no,
I do not experience side-effects’, ‘yes, I do experience side-
effect, but they are not bothersome’, ‘yes, I do experience
side-effects and they are bothersome’, ‘yes, I do experience
side-effects and they are extremely bothersome’) and
whether the patient experienced difficulties enduring long-
term TKI treatment (answer possibilities: ‘no’, ‘yes, a little bit’,
‘yes’, ‘yes, it is very difficult’). The caregiver answered ques-
tions regarding caregiving-related topics, including patients’
independence, hours of caring, caring for more people than
the patient, change in own health as a consequence of giv-
ing care, and neglecting own health as a consequence of
being a caregiver. Duration and setting ((neo-)adjuvant or
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palliative) of treatment was reported by the attend-
ing physician.
Questionnaires assessing general health
The RAND-36 Health Survey is a validated, 36-item question-
naire assessing functional status, well-being and general
health on eight subscales: (1) physical functioning (i.e., activ-
ities of daily living; 10 items), (2) social functioning (i.e., limi-
tations in normal social functioning due to physical and
emotional functioning), (3) role-physical (i.e., limitations in
work and activity of daily living due to physical problems),
(4) role-emotional (i.e., limitations in work and activity of
daily living due to emotional problems), (5) mental health
(i.e., regarding feelings of sadness and anxiety), (6) pain (i.e.,
experience of pain and limitations of activities of daily living
as a consequence of pain), (7) vitality (i.e., feelings of energy
and tiredness) and (8) general health (i.e., subjective evalu-
ation of personal general health). Scores on each subscale
are transformed into a range from 0 to 100. Higher scores
indicate higher levels of functioning, well-being and general
health. The Dutch version of the questionnaire has been vali-
dated and showed sufficient to good internal consistency
(Cronbach’s a 0.71–0.92) [14].
The Self-administered Comorbidity Questionnaire is a
questionnaire, assessing whether comorbidity is present, and
if so, is treated and/or leads to impairments in daily function-
ing. The questionnaire consists of 14-items with defined
medical conditions and three blank spaces to complete
when a medical condition is present, but not defined in the
14-items [15].
Questionnaires assessing mental health and
social support
The Hospital Anxiety and Depression Scale (HADS) is a vali-
dated, 14-item self-assessment questionnaire to assess psy-
chological distress [16,17]. Total scores range between 0 and
42. Each item is rated on a scale from 0 (not at all) to 3 (very
much). Higher scores indicate higher levels of distress. To
identify high levels of distress on an individual basis, for
patients we used the validated cutoff score for cancer
patients of 11 or higher [18]. For caregivers, a cut-off score
of 12 was used. This cut-off score is validated in several
Dutch populations and used in other clinical studies in with
cancer caregivers in the Netherlands [16,19].
The Social Support List – Discrepancies (SSL-D) contains
34-items to assess discrepancies between an individual’s’
need for social support and their perceived social support.
The questionnaire assesses six types of social support,
namely emotional interactions, problem-focused emotional
support, esteem support, instrumental interactions, social
companionship and informational support. The main ques-
tion is ‘Does it ever occur that people…’, which is followed
by a statement, for example ‘offer you mental support’ or
‘offer you good advice’ or ‘offer you constructive feedback’.
The answer possibilities are (1) ‘I miss this, I would like to
receive this more often’, (2) I do not miss this, but it would
be fortunate to receive this more often, (3) The support
meets my needs exactly, (4) This happens too often, it would
be fortunate when it happens less. The score on every item
is transformed to scores ranging from 34 to 136, with higher
scores indicating more unmet need for social sup-
port [20,21].
Marital satisfaction was measured with the ‘marital sat-
isfaction’ subscale of the Maudsley Marital Questionnaire
(MMQ), a validated questionnaire to assess marital satisfac-
tion. This is a 10-item questionnaire, answered on a 9-point
scale (0–8), ranging from 0 to 80. Higher scores indicate
decreased marital satisfaction [22]. We instructed participants
of this study only to complete this questionnaire if they were
a couple.
Questionnaire assessing giving care to a significant other
The Self-Perceived Pressure from Informal Care (SPPIC) is a
Dutch, validated questionnaire to assess caregivers’ self-
perceived stress as a reaction to providing informal care. In
the Netherlands, the questionnaire is often used among can-
cer caregivers to measure their perceived burden during
patients’ treatment. The questionnaire assesses how per-
ceived pressure as a consequence of giving care to a signifi-
cant other interferes with caregivers’ personal interests,
where ‘personal interest’ is defined as the possibility to have
own thoughts, activities and/or other roles they want to fulfil
in life. Examples of questions are ‘As a consequence of the
situation of my significant other, less time is available man-
aging my personal life’ or ‘Combining the responsibility for
my significant other and my family and work is challenging’.
It consists of a nine-item, five-point Rasch scale. According to
the questionnaire manual, the scores are dichotomized to 0
(‘no!’ and ‘no’) and 1 (‘yes!’, ‘yes’ and ‘more or less’). The total
scores range from 0 to 9, with higher scores indicating high
levels of burden [23]. Total scores on the scale were defined
as low (0–3), moderate (4–6) and high levels of burden. (7–9)
This was in accordance with a study performed among care-
givers of patients with oesophageal cancer [24].
Statistical analyses
Analyses were performed using SPSS software version 20
(SPSS Inc. Chicago, IL, USA). For analysis, incomplete dyads
were excluded. Descriptive statistics were used for sample
characteristics. To explore the association between patients’
distress and caregivers’ burden and distress, Pearsons correla-
tions were performed. For the analysis of low/moderate ver-
sus high levels of burden and low versus high levels of
distress, we performed independent-samples T-test for con-
tinuous variables when equal distribution of the number of
participants between group was expected. The
Mann–Whitney U test was performed when normal distribu-
tion was not met between groups. For categorical variables,
Chi square tests were performed and Fishers exact test was
conducted when the condition of a maximum of 20% with
5 expected counts was not met. We explored whether
there was a difference between low/moderate (score 0–6)
versus high levels (7–9) of burden for the following
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variables: age, gender, relation to patient (spouse versus
non-spouse), employment (yes/no), independence patient
(yes/no), caring for more people than the patient with GIST
(yes/no), hours of caring (<8 h/>8 h), duration of TKI use
(months), setting of TKI use (adjuvant versus palliative), side
effects of TKI use (yes/no), caregivers’ comoribidity (yes/no),
distress (HADS), discrepancies in social support (SSL-D), gen-
eral health (RAND-36) and marital satisfaction (MMQ). We
applied all the same variables to explore differences between
high and low levels of distress, where distress (HADS) was
replaced for burden (SPPIC). For all analysis, a p-value of
<.05 was considered as a statistically significant difference.
Results
Caregivers’ and patients’ characteristics
Seventy-one couples were eligible, of whom 61 (84%) cou-
ples participated by returning the completed questionnaires.
Reasons for not participating in the study were the expect-
ation that filling out the questionnaires was too confronting
(two couples) and unknown reason (eight couples). Table 1
shows caregivers’ and patients’ demographic characteristics,
patients’ treatment-related characteristics and caregiving-
related characteristics. The median age of caregivers’ was 60
years; 66% were female and 78% were the patient’s’ spouse.
The median age of patients was 66 years, and 43% were
female. The mean duration of patients’ treatment with a TKI
was 44 months (SD 34).
Caregivers’ general health (RAND-36), comorbidities
(SCQ), burden (SPPIC), distress (HADS), marital
satisfaction (MMQ) and discrepancies between need for
social support and perceived social support (SSL-D)
Overall, scores on the RAND-36 showed that caregivers’ gen-
eral health was not significantly different from values of nor-
mative comparatives, except for pain, which was significantly
worse (p< .001). Details are shown in Table 2. The number
of comorbidities affecting caregivers ranged from 0 (29.5%)
to 7 (1.6%), with most between 0 and 2 (84%); 70% had one
or more comorbidit(y)(ies). An overview of the number of
comorbidities is given in Table 1. An overview of the nature
and treatment of comorbidities, is shown in Table 3.
The mean score for burden was 2.4 (SD 2.3; range 0–9).
Seventy-four percent (n¼ 45) reported low, 16% (n¼ 10)
moderate and 10% (n¼ 6) high levels of burden. Of the care-
givers who reported low levels of burden, 18% (n¼ 11) expe-
rienced no burden at all. The mean level of distress was 8.1
(SD 5.7; range 0–42) and 23% of the caregivers experienced
high levels of distress. Discrepancies in social support
showed a mean score of 39.2 (SD 6.7; range 34–136). Mean
score for marital satisfaction was 9.3 (SD 9.3; range 0–80).
Caregivers’ burden was significantly correlated with their
own distress (r 0.584, p< .01) and patients’ distress (r 0.442,
p< .01). Furthermore, caregivers’ distress was significantly
correlated with patients’ distress (r 0.375, p< .01).
Patients’ general health (RAND-36), comorbidities
(SCQ), distress (HADS), marital satisfaction (MMQ) and
discrepancies between need for social support and
perceived social support (SSL-D)
Patients’ general health was significantly different to norma-
tive comparatives for every dimension measured, except for
mental health, which was comparable. Details are shown in
Table 2. The number of comorbidities affecting patients
ranged from 0 (21.3%) to 6 (4.9%), with the most between 0
and 3 (85.2%); 78.7% had one or more comorbidit(y)(ies).
Details are given in Table 1. Overall, the mean level of
patients’ general distress was 9.6 (SD 6.8; range 0–42) and
34% of patients experienced high levels of distress.
Discrepancies in social support showed a mean score of 38.7
(SD 6.2; range 34–136). For marital satisfaction patients
reported a mean score of 9.3 (SD 10.0; range 0–80).
Exploring caregivers’ highlevels of burden and distress
When the caregivers who experienced high burden (n¼ 6,
10%) were compared to caregivers with low and moderate
burden (n¼ 55, 90%), the caregivers with high levels of bur-
den experienced significantly more distress (p¼ .003), lower
mental health (p¼ .033), less vitality (p¼ .019) and lower
general health (p¼ .038). High levels of burden were found
in non-spouses (p¼ .017), caregivers of patients experiencing
more treatment side-effects (p¼ .016), those who spent more
hours caring (p¼ .046) and those who were caring for more
than one person (p¼ .038). All caregivers with high levels of
burden, had one of more comorbidit(y)(ies). Details are
shown in Table 4.
When caregivers with high levels of distress (n ¼ 14,
23%) were compared to caregivers with low levels of distress
(n¼ 47, 77%), the caregivers with high levels of distress
experienced significantly more burden (p¼ .001), lower levels
of social functioning (p¼ .016), more role physical problems
(p¼ .007), more role emotional problems (p¼ .043), lower
levels of mental health (p< .001), less vitality (p< .001), lower
levels of general health (p¼ .006). Furthermore, high levels
of distress were found in caregivers of patients who were
perceived as less independent (p¼ .008) and in caregivers
caring for more than one person (p¼ .025). For caregivers
with high levels of distress 79% had one or more comorbidi-
t(y)(ies), but there was no difference in whether the caregiver
had comorbidities (yes/no) between groups with low versus
higher levels of distress. Details are shown in Table 5.
The duration of treatment and setting in which the treat-
ment was given (adjuvant or for metastatic GIST) did not dif-
fer between caregivers with high or low/moderate levels of
burden, nor high and low levels of distress.
Discussion
The goal of this study was to explore caregivers’ burden and
distress during the patients’ long-term treatment with TKI for
GIST. Overall, caregivers of patients treated for GIST seem to
manage well, as their levels of perceived burden and distress
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are low, their perceived general health is good and similar to
the healthy population, their marital satisfaction seems good
and they do not seem to experience discrepancies in social
support. Fortunately, 90% of caregivers in this study per-
ceived low to moderate levels of burden, of whom 18% did
not perceive any burden at all. The burden of caregivers of
the patients with cancer differ, but hardly any studies are
performed in caregivers of patients treated with long-term
TKIs. In a study by Haj Mohammed et al., where caregivers of
oesophageal cancer patients were studied for burden
Table 1. Caregivers’ and patients’ characteristics.
Characteristics participants Details Caregiver (n¼ 61), n (%) Patient (n¼ 61), n (%)
Gender Female 40 (66) 26 (43)
Age, median Years (IQR) 60 (51–68) 66 (55–75)
Educational levela Lower education (ISCED <4) 36 (60) 41 (67)
Higher education (ISCED >4) 24 (40) 20 (33)




Employment statusc Paid work 28 (47) 12 (20)
Housekeeper 8 (13) 14 (23)
Voluntary work 5 (8) 7 (12)
Disablement insurance act 3 (5) 11 (18)
Retired 22 (37) 27 (44)
TKI treatment duration Month (SD) 44 (34)
TKI treatment Adjuvant, n (%) 12 (20)
Palliative, n (%) 49 (80)
Side-effects treatment No, n (%) 5 (9)
Yes, minimal, n (%) 24 (41)
Yes, bothersome, n (%) 25 (42)
Yes, severe, n (%) 5 (9)
Difficulties enduring TKI treatment No, n (%) 40 (66)
Yes, somewhat, n (%) 12 (20)
Yes, , n (%) 7 (12)
Yes, serious, n (%) 1 (2)
Hours of caregiving (weekly), n (%) < 8, n (%) 47 (84)
8–16, n (%) 5 (9)
16–24, n (%) 0 (0)
>24, n (%) 4 (7)
Patients’ indepence, n (%) Completely independent 42 (69)
Mostly independent 14 (23)
Partly independent, partly dependent 4 (6)
Mostly dependent 1 (2)
Caregiving to other people, other than patienta Yes 9 (15)
No 51 (85)
General health changed as a consequence of giving care Yes 1 (2)
Somewhat 9 (15)
No 51 (84)
Neglecting own health as a consequence of giving care Yes 1 (2)
Somewhat 8 (13)
No 52 (85)
Number of comorbidities 0 18 (30) 13 (21.3)
1 19 (31) 15 (24.6)
2 13 (21) 18 (29.5)
3 5 (8) 6 (9.8)
4 3 (5) 2 (3.3)
5 1 (2) 4 (6.6)
6 1 (2) 3 (4.9)
7 1 (2) 0 (0)
ICR: interquartel range; ISCED: International Standard Classification of Education; SD: standard deviation.
aOne missing;
btwo missing;
cmore than one option possible.
Table 2. RAND-36 Health Survey outcomes of caregivers and patients in relation to healthy population.
RAND subscale Caregiver mean scores (SD) Patient mean scores (SD) Healthy population mean scores (SD)
Physical functioning 87.6 (19.9) 69 (21.2) 81.9 (23.2)
Social functioning 83.5 (16.7) 77.5 (24.8) 86.9 (20.5)
Role physical 83.2 (30.1) 63 (43.4) 79.4 (35.5)
Role emotional 87.9 (28.4) 69.4 (42.6) 84.1 (32.3)
Mental health 77.2 (15.8) 76.3 (15.7) 76.8 (18.4)
Pain 49.1 (5.4) 48.1 (7.6) 79.5 (25.6)
Vitality 70.1 (17.5) 61 (19.1) 67.4 (19.9)
General health 72.7 (17.8) 49.4 (20.9) 72.7 (22.7)
RAND: Rand-36 Health Survey [14]; SD: standard deviation.Significantly different from healthy population at p< .01 level.
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approximately 3 years after being treated with curative
intent with neo-adjuvant chemoradiotherapy followed by
resection, the percentage of low and moderate burden was
81% [24]. In a study by Hsu et al., exploring caregivers’ bur-
den of patients treated for cancer in early stage of disease
(30%) or advanced disease (70%) for haematological and
solid malignancies, low and moderate burden was found in
75% of caregivers [25]. Additionally, the multivariate analyses
in the study by Hsu et al. showed that caregivers who were
employed and providing support for activities of daily living,
were at greater risk of high levels of burden [25]. According
to the caregivers in our study, 84% of the caregivers spent
less than 8 h weekly providing care to the patient and 92%
of GIST patients: function independently of their caregivers
in daily life, although the questionnaire did not define
exactly what is meant by functioning independently. This
may explain why the levels of burden in caregivers is per-
ceived as low. Another reason may be that caregivers in our
study experience low levels of discrepancies between their
need for social support and their perceived social support. It
Table 3. Caregivers’ comorbidities, treatment and perceived limitations in daily life.
Comorbidity Total, n (%) Treatment, n (% of total) Impairments in daily functioning, n (% of total)
Heart disease 7 (12) 7 (100) 4 (57)
Stroke 0 (0) 0 (0) 0 (0)
Hypertension 12 (20) 10 (83) 0 (0)
Astma, chronic bronchitis, COPD 4 (7) 2 (33) 1 (25)
Diabetes 1 (2) 1 (100) 0 (0)
Ulcus stomach 0 (0) 0 (0) 0 (0)
Kidney disease 0 (0) 0 (0) 0 (0)
Liver disease 0 (0) 0 (0) 0 (0)
Anaemia or other blood diseases 0 (0) 0 (0) 0 (0)
Cancer 2 (3) 1 (50) 0 (0)
Thyroidic disease 2 (3) 2 (100) 1 (50)
Depression 4 (7) 1 (25) 3 (75)
Arthrosis 17 (28) 6 (40) 8 (57)
Back pain 15 (25) 5 (36) 8 (57)
Reumatoid arthritis 3 (5) 1 (33) 1 (50)
Other 23 (37) 13 10
Table 4. Overview of demographical, treatment-related, care-related and health-related variables of caregivers stratified for low/moderate levels
versus high levels of burden.
Variables Low/moderate levels of burden, n¼ 55 High levels of burden, n¼ 6 p value
Gender Male, n (%) 20 (95.2) 1 (4.8) .654
Female, n (%) 35 (87.5) 5 (12.5)
Relation to patient Spouse, n (%) 45 (95.7) 2 (4.3) .017
Non spouse, n (%) 9 (69.2) 4 (30.8)
Employment Yes, n (%) 25 (89.3) 3 (10.7) 1.000
No, n (%) 29 (90.6) 3 (9.4)
Side-effects Yes, n (%) 22 (81.5) 5 (18.5) .016
No, n (%) 32 (100) 0 (0)
Setting TKI use Adjuvant, n (%) 12 (100) 0 (0) .588
Palliative, n (%) 43 (87.8) 6 (12.2)
Independence patient Yes, n (%) 52 (92.9) 4 (7.1) .071
No, n (%) 3 (60) 2 (40)
Hours of caring <8 h, n (%) 44 (93.6) 3 (6.4) .046
>8 h, n (%) 6 (66.7) 3 (33.3)
Caring for more than one person Yes, n (%) 6 (66.7) 3 (33.3) .038
No, n (%) 48 (94.1) 3 (5.9)
Comorbidity caregiver Yes, n (%) 37 (86) 6 (14) .167
No, n (%) 18 (100) 0 (0)
Age Years 31.2 29.5 .827
Duration TKI treatment Months 29.2 42.8 .085
HADS total (caregiver) Mean ranks 28.9 50.1 .003
SSL-D Mean ranks 26.9 36.9 .137
MMQ – marital satifaction Mean ranks 23.2 30.5 .450
RAND physical functioning caregiver Mean ranks 29.9 30.2 .977
RAND social functioning caregiver Mean ranks 31.5 21.3 .156
RAND role physical caregiver Mean ranks 29.9 25.2 .458
RAND role emotional caregiver Mean ranks 30.2 22.6 .162
RAND mental health caregiver Mean ranks 31.1 15.7 .033
RAND vitality caregiver Mean ranks 31.2 14.5 .019
RAND pain caregiver Mean ranks 30.0 24.2 .483
RAND general health caregiver Mean ranks 31.1 16.0 .038
TKI: tyrosine kinase inhibitor; HADS: Hospital Anxiety and Despression Scale; SSL-D: Social Support List – Discrepancies; RAND: Rand-36 Health
Survey; MMQ: Maudsley Marital Questionnaire.Statistically significant values at p< .05 level.Statistically significant values at p< .01 level;
Continuous variables were tested with Mann–Whitney U, mean ranks are reported; categorical variables were tested with Fishers exact, numbers
and percentages are reported.
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is known that social support is vital in preventing high levels
of burden [10]. Furthermore, it is known that good copings
skills may protect caregivers from overstretching themselves
[10]. As the average duration of treatment of the patients in
our sample was 44 months, this may have given caregivers
time to adjust to patients’ disease and treatment. On the
other hand, our study showed that there was no difference
between the groups of low/moderate and high levels of bur-
den and low and high levels of distress according to the dur-
ation of treatment. This may also suggest that there is a
group of caregivers that is not able to adjust over time.
Overall, we found that levels of distress were low. Distress
in caregivers of patients on active treatment can arise due to
worries about the efficacy of treatment, management of
side-effects, social isolation, lack of experience when caring
for a significant other and complexity of care [13].
Considering these risk factors, caregivers in our study experi-
enced low levels of unmet needs for social support and the
majority of the caregivers spent a low number of hours of
providing care, which might protect them from distress. On
the other hand, 50% of the patients in this study reported
bothersome or severe side-effects of treatment and 34% of
the patients experienced high levels of distress. The latter
was associated with caregivers’ levels of distress and burden.
This, together with the need for continuous treatment,
anxiety about computed tomography (CT) scans and results,
may have contributed to high levels of distress in 23%
of caregivers.
It is vital that attention is given to caregivers with high lev-
els of distress and burden, as active treatment for patients
with GIST is at least three years in the adjuvant setting and
may be much longer with metastatic GIST. We identified a
group of caregivers with high levels of burden (10%) or dis-
tress (23%), and compared them to the group of caregivers
with low/moderate levels of burden or low levels of distress.
Caregivers with high levels of burden, had significantly lower
levels of mental health (i.e., feelings of sadness and anxiety),
vitality (i.e., tiredness and lower levels of energy) and general
health (i.e., perception of lower quality of personal general
health). It is known that high levels of burden are associated
with depressive symptoms, or even depression as an outcome,
and our findings are therefore consistent with other studies
[10,13]. Regarding their general health, 100% of the caregivers
with high levels of burden had one or more comorbidities,
which is higher than the average for the Dutch population
(between 42 and 52% above 55 years) [26]. Nevertheless,
there was no significant difference in the number of comor-
bidities between the group with low/moderate and high lev-
els of burden. This may be explained by the fact that most of
the comorbidities reported by caregivers did not cause
Table 5. Overview of demographical, treatment-related, care-related and health-related variables of caregivers stratified for low versus
high levels of distress.
Variables Low levels of distress, n¼ 47 High levels of distress, n¼ 14 p value
Gender Male, n (%) 19 (90.5) 2 (9.5) .109
Female, n (%) 28 (70) 12 (30)
Relation to patient Spouse, n (%) 37 (78.7) 10 (21.3) .478
Non spouse, n (%) 9 (69.2) 4 (28.6)
Employment Yes, n (%) 23 (82.1) 5 (17.9) .547
No, n (%) 24 (75) 8 (25)
Side-effects Yes, n (%) 19 (70.4) 8 (29.6) .224
No, n (%) 27 (84.4) 5 (15.6)
Setting TKI use Adjuvant, n (%) 9 (75) 3 (25) 1.000
Palliative, n (%) 38 (77.6) 11 (22.4)
Independence patient Yes, n (%) 46 (82.1) 10 (17.9) .008
No, n (%) 1 (20) 4 (80)
Hours of caring <8 h, n (%) 37 (78.7) 10 (21.3) .206
>8 h, n (%) 5 (55.6) 4 (44.4)
Caring for more than one person Yes, n (%) 4 (44.4) 5 (55.6) .025
No, n (%) 42 (82.4) 9 (17.6)
Comorbidity caregiver Yes, n (%) 15 (83.3) 3 (16.7) .525
No, n (%) 32 (74.4) 11 (25.6)
Age Years 30.3 33.2 .595
Duration TKI treatment Months 31.4 29.7 .757
SPPIC Mean ranks 26.8 45.1 .001
SSL-D Mean ranks 27.2 30.7 .475
MMQ – marital satifaction Mean ranks 21.9 29.2 .131
RAND physical functioning caregiver Mean ranks 31.5 25.1 .205
RAND social functioning caregiver Mean ranks 33.4 21.0 .016
RAND role physical caregiver Mean ranks 32.1 20.6 .007
RAND role emotional caregiver Mean ranks 31.2 24.1 .043
RAND mental health caregiver Mean ranks 35.3 11.3 .000
RAND vitality caregiver Mean ranks 34.1 15.1 .000
RAND pain caregiver Mean ranks 29.9 28.0 .669
RAND general health caregiver Mean ranks 31.1 16.0 .006
TKI: tyrosine kinase inhibitor; HADS: Hospital Anxiety and Despression Scale; SSL-D: Social Support List – Discrepancies; RAND: Rand-36
Health Survey; MMQ: Maudsley Marital Questionnaire.Statistically significant values at p< .05 level.Statistically significant values at p< .01 level; continuous variables were tested with Mann-Whitney U, mean ranks are reported; cat-
egorical variables were tested with Fishers exact, number and percentages are reported.
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limitations in daily functioning, except for arthrosis, back pain
and rheumatoid arthritis. The latter may explain why care-
givers, overall, had significantly higher pain scores on RAND-
36 compared with their normative comparatives. Nevertheless,
only 2% reported they experienced a decline in their health
as a consequence of caring for their significant other.
Caregivers who perceived high levels of burden spent sig-
nificantly more hours caring for their significant other and
were more likely to care for more people other than the
GIST patient alone. Adelman et al. described in their review
that spending more hours caring is a risk factor for burden
and Northouse et al. described that it is associated with dis-
ruption to their own lifestyle and interference with their own
social activities causing social isolation [10,11]. The latter may
on its own contribute to distress, as we found that caregivers
with high levels of distress had significantly more problems
with social functioning. It may be that what normally pro-
tects caregivers against overstraining, such as moving on
with their own life, their employment and social interaction,
is insufficient and may lead to (serious) health problems, as
found in other studies [10,13,27]. Furthermore, caregivers
experiencing high levels of burden were shown to care for
patients who had significantly more treatment-related side-
effects. An important TKI-related side-effect is severe fatigue,
which was studied by Poort et al. This study showed that
30% of patients treated with a TKI for GIST were severely
fatigued and this influenced their quality of life and impaired
their overall functioning [28]. Pitceathly et al. described that
caregivers’ distress increases when a patient has more phys-
ical complaints [27]. It is conceivable that side-effects may
influence many aspects of a patient’s life and therefore also
interfere with the well-being of caregivers, as they cope with
the disease and its treatment as a couple [7,8].
This study had a number of limitations. Firstly, as far as
we know, there are no validated cut-off points for measuring
burden and distress in caregivers with the SPPIC and HADS,
respectively. The SPPIC is a validated instrument to measure
burden and is often used in clinical settings to measure can-
cer caregivers’ burden. However, no reference data are avail-
able and there are no studies performed establishing
validated cut-off scores. Nevertheless, for clinical practice,
mean scores are often more difficult to interpret and during
consultation it is useful to evaluate whether a caregiver
experiences moderate or high levels of burden, in order to
prioritise the need for support. Therefore, we decided to
dichotomise with low and moderate versus high levels of
burden, as with the study performed by Haj Mohammed
et al. [24] Using this, we tried to identify the most vulnerable
group of caregivers and explore risk factors for high levels of
burden. Future studies could also focus on the group with
moderate levels of burden or decide to combine moderate
and high levels of burden, since moderate levels of burden
could be of importance for caregivers of patients on long-
term treatment. The HADS is also a validated questionnaire
and often used to screen for distress among caregivers in
clinical practice in the Netherlands. As for burden, to evalu-
ate whether a caregiver experiences distress, a cut-off score
could be helpful, however, there are no established cut-off
scores to measure higher levels of caregivers’ distress.
Therefore, we adopted a cut-off score of 12, which is often
used when screening for distress in general practice, and
seems to have a satisfactory sensitivity for the total HADS
scale, important for preventing too many false negatives
[16]. We acknowledge that the HADS is especially useful as a
first screening for distress and we want to emphasize that it
is important to explore the cause of distress further when
finding cases using cut-off scores.
In order to explore differences between low/moderate
and high levels of burden and low and high levels of dis-
tress, we used multiple separate tests. With these tests we
can only explore whether there were differences between
the groups, without drawing conclusions about its cause or
associations between variables. To determine association
between the variables and possible causes of burden and
distress, a multiple regression analysis would be of added
value. Due to our small sample size we did not perform mul-
tiple regression analyses. The generalizability of this study
may also be limited due to the small sample size. Future
studies could perform these analyses with a larger sample
size in order to prevent type II error. These studies could
focus on this association to better understand burden and
distress in this group of caregivers, using multiple regression
analyses. This was a cross-sectional study and therefore, we
cannot draw firm conclusions about causality. We also
included both patients receiving curative, i.e., adjuvant, and
palliative treatment, however this did not translate in differ-
ences in perceived burden and distress. We only studied a
group of patients who were on TKI treatment for at least six
months and had a prognosis of >12 weeks. Therefore, our
results cannot be generalised to caregivers of patients at the
start of TKI treatment or caregivers of GIST patients in the
terminal phase of their lives. Our sample also did not include
caregivers who were under the age of 18 years and were not
able to communicate in the Dutch language. These care-
givers could be another interesting group of caregivers and
it would be interesting to study them in the future. Lastly,
there were two couples who did not want to participate as
they felt that the questionnaires were too confronting. It is
conceivable that these patients and/or caregiver may suffer
from burden and/or distress. It is therefore possible that the
levels of distress and burden might be even higher than
observed in this study. In conclusion, caregivers of patients
on long-term treatment for GIST with TKIs appear to manage
well. Nevertheless, it is important to recognise caregivers
who have high levels of burden and distress, associated with
physical and mental health-related problems. Interestingly,
the stage of disease for which the patient was treated, and
the duration of the treatment, did not seem to impact the
burden and distress, however treatment-related side-effects
and more hours of caring were related. Healthcare professio-
nals currently aim to involve caregivers in patient care
through providing adequate information on how to deal
with patients’ treatment. Awareness of caregivers’ health
problems should be improved. Recognizing the burden and
distress is an important initial step, however management
may be challenging. Future research could focus on how to
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implement screening for caregivers’ burden and distress,
how to identify caregivers at high risk for burden and dis-
tress, and how to work with other professionals, including
general practitioners, in caring for the caregiver.
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